NEW

Johnson & Johnson to Acquire Shockwave Medical

Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335 per share in cash, corresponding to an enterprise value of...

Medline Expands Catheter Portfolio

Medline and Consure Medical have announced a new agreement for Medline to exclusively distribute the QiVi MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD)....

FDA Clears Single-use Flexible Ureteroscope

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex™, with full market availability to be announced at a later...

Brainlab, Fujifilm Offer Advanced Neurosurgery Capabilities

FUJIFILM Healthcare Americas Corporation and Brainlab recently announced that Brainlab will be the exclusive U.S. distributor of ARIETTA Precision Ultrasound for neurosurgery applications to be utilized with Brainlab’s surgical navigation systems. ARIETTA Precision,...

FDA Clears New Automated TEE Probe Disinfector

CS Medical has announced the successful clearance of a new Class II medical device by the U.S. FDA and Health Canada, TD 200 Automated TEE Probe Disinfector with TD 12 AquaCide high-level disinfectant.

“Building off the TD 100 platform, TD 200 with TD 12 AquaCide provides customers with a faster high-level disinfection time and an overall quicker total cycle time of ten minutes,” according to a release from CS Medical.

“TD 200 is the first medical device cleared in North America which provides high-level disinfection in just three minutes. The single-use biocide, TD 12 AquaCide comes in granulated form. The TD 12 AquaCide bottle is pierced inside the TD 200, is mixed with water, and heated to create a liquid high-level disinfectant. Simple step-by-step instructions are displayed on the LCD screen for the end-user,” the release adds.

“Today’s news shows CS Medical’s continued commitment to providing products and services that effectively reprocess TEE ultrasound probes. TD 12 AquaCide provides new and exciting opportunities for CS Medical. With a quicker high-level disinfection claim than TD 5 or TD 8, as well as not requiring deactivation prior to disposal, TD 12 AquaCide will reduce reprocessing time and reduce potential ecosystem damage. TD 200 with TD 12 AquaCide is the combination of years of research, development, and commitment by our entire staff,” said Mark Leath, CS Medical president. “TD 200 with TD 12 AquaCide is another example of our pledge to work with health care professionals and other professional organizations to reduce HAIs and increase awareness for a better and safer health care system. In addition to our employees, I am thankful and appreciative of the cooperation and assistance given to us by the TEE ultrasound probe manufacturers, without whom TD 200 with TD 12 AquaCide would not be the product it is today.”

For more information, visit csmedicalllc.com or call 919-255-9472.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X